Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma

ORL

Volumn 69, Issue 4, 2007, Pages 218-225

  Wreesmann, Volkert B ^a   Estilo, Cherry ^b   Eisele, David W ^a   Singh, Bhuvanesh ^b   Wang, Steven J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NONE   (United States)

Author keywords

Fanconi anemia; Head and neck cancer; Real time polymerase chain reaction; Squamous cell carcinoma

Indexed keywords

FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP B PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA GROUP J PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; FANCONI ANEMIA GROUP M PROTEIN; FANCONI ANEMIA PROTEIN; GENE PRODUCT; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FANCONI ANEMIA; FANCONI ANEMIA GENE; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA PRIMERS; DNA, COMPLEMENTARY; DOWN-REGULATION; FANCONI ANEMIA; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; RNA; TONGUE NEOPLASMS;

EID: 34250658382     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101542     Document Type: Article

References (25)

1. Taniguchi T, D'Andrea AD: Molecular pathogenesis of Fanconi anemia: recent progress. Blood 2006;107:4223-4233.
2. Mirchandani KD, D'Andrea AD: The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair. Exp Cell Res 2006;312:2647-2653.
3. Kutler DI, Singh B, Satagopan J, et al: A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003;101:1249-1256.
4. Kutler DI, Auerbach AD, Satagopan J, et al: High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 2003;129:106-112.
5. Kutler DI, Wreesmann VB, Goberdhan A, et al: Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 2003;95:1718-1721.
6. Taniguchi T, Tischkowitz M, Ameziane N, et al: Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 2003;9:568-574.
7. van der Heijden MS, Brody JR, Dezentje DA, et al: In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor. Clin Cancer Res 2005;11:7508-7515.
8. Chirnomas D, Taniguchi T, de la Vega M, et al: Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol Cancer Ther 2006;5:952-961.
9. Singh B, Gogineni SK, Sacks PG, et al: Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res 2001;61:4506-4513.
10. 2+ signaling and cisplatin resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg 2006;132:19-24.
11. Ishisaki A, Oida S, Momose F, et al: Identification and characterization of autocrinemotility-factor-like activity in oral squamous-cell-carcinoma cells. Int J Cancer 1994;59:783-788.
12. Wagner W, Ansorge A, Wirkner U, et al: Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis. Blood 2004;104:675-686.
13. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
14. Wreesmann VB, Singh B: Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: biologic insights and clinical opportunities. J Oral Pathol Med 2005;34:449-459.
15. Vogelstein B, Kinzler KW: Cancer genes and the pathways they control. Nat Med 2004;10:789-799.
16. Tremblay S, Pintor dos Reis P, Bradley G, et al: Young patients with oral squamous cell carcinoma: study of the involvement of GSTP1 and deregulation of the Fanconi anemia genes. Arch Otolaryngol Head Neck Surg 2006;132:958-966.
17. Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT: Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene 2004;23:1000-1004.
18. Tischkowitz MD, Morgan NV, Grimwade D, et al: Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. Leukemia 2004;18:420-425.
19. van der Heijden MS, Yeo CJ, Hruban RH, Kern SE: Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res 2003;63:2585-2588.
20. D'Andrea AD: The Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers. Cell Cycle 2003;2:290-292.
21. D'Andrea AD, Grompe M: The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 2003;3:23-34.
22. Wreesmann VB, Shi W, Thaler HT, et al: Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol 2004;22:3965-3972.
23. Wreesmann VB, Sieczka EM, Socci ND, et al: Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res 2004;64:3780-3789.
24. van der Heijden MS, Brody JR, Gallmeier E, et al: Functional defects in the Fanconi anemia pathway in pancreatic cancer cells. Am J Pathol 2004;165:651-657.
25. van Zeeburg HJ, Snijders PJ, Pals G, et al: Generation and molecular characterization of head and neck squamous cell lines of Fanconi anemia patients. Cancer Res 2005;65:1271-1276.